These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20347901)

  • 1. Analytical characterization and comparison of the blood-brain barrier permeability of eight opioid peptides.
    Van Dorpe S; Adriaens A; Polis I; Peremans K; Van Bocxlaer J; De Spiegeleer B
    Peptides; 2010 Jul; 31(7):1390-9. PubMed ID: 20347901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desirability function combining metabolic stability and functionality of peptides.
    Van Dorpe S; Adriaens A; Vermeire S; Polis I; Peremans K; Spiegeleer BD
    J Pept Sci; 2011 May; 17(5):398-404. PubMed ID: 21294224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat.
    Isakovic AJ; Abbott NJ; Redzic ZB
    J Neurochem; 2004 Jul; 90(2):272-86. PubMed ID: 15228584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration.
    Negri L; Lattanzi R; Tabacco F; Scolaro B; Rocchi R
    Br J Pharmacol; 1998 Aug; 124(7):1516-22. PubMed ID: 9723966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation.
    Egleton RD; Mitchell SA; Huber JD; Palian MM; Polt R; Davis TP
    J Pharmacol Exp Ther; 2001 Dec; 299(3):967-72. PubMed ID: 11714884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics.
    Boström E; Simonsson US; Hammarlund-Udenaes M
    Drug Metab Dispos; 2006 Sep; 34(9):1624-31. PubMed ID: 16763013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of blood-brain barrier permeability to PYY3-36 in the mouse.
    Nonaka N; Shioda S; Niehoff ML; Banks WA
    J Pharmacol Exp Ther; 2003 Sep; 306(3):948-53. PubMed ID: 12750431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-brain barrier permeability and bioavailability of a highly potent and mu-selective opioid receptor antagonist, CTAP: comparison with morphine.
    Abbruscato TJ; Thomas SA; Hruby VJ; Davis TP
    J Pharmacol Exp Ther; 1997 Jan; 280(1):402-9. PubMed ID: 8996221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of combined chemical modifications to enhance the blood-brain barrier permeability and pharmacological activity of endomorphin-1.
    Liu HM; Liu XF; Yao JL; Wang CL; Yu Y; Wang R
    J Pharmacol Exp Ther; 2006 Oct; 319(1):308-16. PubMed ID: 16803861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1.
    Price TO; Samson WK; Niehoff ML; Banks WA
    Peptides; 2007 Dec; 28(12):2372-81. PubMed ID: 18006117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-brain barrier permeability of novel [D-arg2]dermorphin (1-4) analogs: transport property is related to the slow onset of antinociceptive activity in the central nervous system.
    Deguchi Y; Naito Y; Ohtsuki S; Miyakawa Y; Morimoto K; Hosoya K; Sakurada S; Terasaki T
    J Pharmacol Exp Ther; 2004 Jul; 310(1):177-84. PubMed ID: 15031301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system distribution kinetics of indinavir in rats.
    Hamidi M
    J Pharm Pharmacol; 2007 Aug; 59(8):1077-85. PubMed ID: 17725849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective brain to blood efflux transport of para-aminohippuric acid across the blood-brain barrier: in vivo evidence by use of the brain efflux index method.
    Kakee A; Terasaki T; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1018-25. PubMed ID: 9399971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permeability of the blood-brain barrier to HIV-1 Tat.
    Banks WA; Robinson SM; Nath A
    Exp Neurol; 2005 May; 193(1):218-27. PubMed ID: 15817280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro evidence for nonrestricted transport of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein tetraacetoxymethyl ester at the blood-brain barrier.
    Hirohashi T; Terasaki T; Shigetoshi M; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Feb; 280(2):813-9. PubMed ID: 9023295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier.
    Gao B; Hagenbuch B; Kullak-Ublick GA; Benke D; Aguzzi A; Meier PJ
    J Pharmacol Exp Ther; 2000 Jul; 294(1):73-9. PubMed ID: 10871297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer's Tg2576 mice.
    LaRue B; Hogg E; Sagare A; Jovanovic S; Maness L; Maurer C; Deane R; Zlokovic BV
    J Neurosci Methods; 2004 Sep; 138(1-2):233-42. PubMed ID: 15325132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of an influx transporter in the blood-brain barrier transport of naloxone.
    Suzuki T; Ohmuro A; Miyata M; Furuishi T; Hidaka S; Kugawa F; Fukami T; Tomono K
    Biopharm Drug Dispos; 2010 May; 31(4):243-52. PubMed ID: 20437463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nesfatin-1 crosses the blood-brain barrier without saturation.
    Pan W; Hsuchou H; Kastin AJ
    Peptides; 2007 Nov; 28(11):2223-8. PubMed ID: 17950952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permeability of the mouse blood-brain barrier to murine interleukin-2: predominance of a saturable efflux system.
    Banks WA; Niehoff ML; Zalcman SS
    Brain Behav Immun; 2004 Sep; 18(5):434-42. PubMed ID: 15265536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.